GlassScriptPhysician profile
Alexis Colter
NPI 1801286166
$503.73
in general payments reported to CMS, 2019-2025
16 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.29 · 2022: $60.11 · 2023: $139 · 2024: $37.98 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $384.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $86.24 | 2021-2025 | Liletta |
| Hologic Sales and Service, LLC | $51.49 | 2021-2022 | |
| Coopersurgical, INC. | $42.04 | 2025 | Sos, Paragard T 380a |
| Sumitomo Pharma America, INC. | $39.51 | 2023-2025 | Myfembree |
| C. R. Bard, INC. & Subsidiaries | $37.98 | 2024 | Arista Ah Flexitip |
| Ethicon US, LLC | $34.22 | 2023 | Enseal, Ethicon |
| Daiichi Sankyo INC. | $27.54 | 2021 | |
| Myovant Sciences INC. | $25.94 | 2022 | |
| Mimedx Group, INC. | $24.92 | 2025 | |
| Mayne Pharma Commercial LLC | $23.55 | 2025 | |
| Conmed Corporation | $21.95 | 2023 | Airseal |
| Lilly USA, LLC | $20.95 | 2025 | Zepbound, Mounjaro |
| Organon LLC | $20.81 | 2025 | Nexplanon |
| Pacira Pharmaceuticals Incorporated | $17.02 | 2025 | Exparel |
| Meditrina | $15.90 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $13.67 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Colter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.